Sigma-Aldrich Posts 7 Percent Q4 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter 2012 revenues grew 7 percent, driven by strong sales for its SAFC business unit.

The St. Louis-based chemicals and research products firm reported total revenues of $655 million for the three months ended Dec. 31, compared to $610 million for the fourth quarter of 2011. It fell short of the consensus Wall Street estimate for revenues of $659.6 million. On an organic basis, the firm's revenues grew 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.